CymaBay Therapeutics
CBAY
$32.48
Share price
0.00%
Change (1 day)
221.27%
Change (1 year)
Categories
CymaBay Therapeutics (CBAY) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.14 B
According to CymaBay Therapeutics 's latest financial reports the company's total liabilities are $0.14 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CymaBay Therapeutics - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.14 B | 34.75% |
| 2022-12-31 | $0.10 B | 52.34% |
| 2021-12-31 | $69.38 M | 523.99% |
| 2020-12-31 | $11.11 M | -42.62% |
| 2019-12-31 | $19.37 M | 18.68% |
| 2018-12-31 | $16.32 M | -15.39% |
| 2017-12-31 | $19.3 M | 25.15% |
| 2016-12-31 | $15.42 M | 3.06% |
| 2015-12-31 | $14.96 M | -36.66% |
| 2014-12-31 | $23.62 M | 69.91% |
| 2013-12-31 | $13.9 M | -95.87% |
| 2012-12-31 | $0.33 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 96,237.15% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $82.48 B | 57,811.25% | 🇺🇸 USA |
 Xencor XNCR | $0.28 B | 99.09% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | $2.71 B | 1,805.67% | 🇺🇸 USA |